These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 6480444)
1. HPLC assay for 2-(3-aminopropylamino)ethanethiol (WR-1065) in plasma. McGovern EP; Swynnerton NF; Steele PD; Mangold DJ Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1517-20. PubMed ID: 6480444 [TBL] [Abstract][Full Text] [Related]
2. An improved HPLC assay for S-2-(3-aminopropylamino)ethyl phosphorothioate (WR-2721) in plasma. Swynnerton NF; McGovern EP; Niño JA; Mangold DJ Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1521-4. PubMed ID: 6090354 [TBL] [Abstract][Full Text] [Related]
3. Measurement of WR-1065 in plasma: preliminary pharmacokinetics in the beagle. Swynnerton NF; Huelle BK; McGovern EP; Mangold DJ; Ludden TM Res Commun Chem Pathol Pharmacol; 1986 Nov; 54(2):255-69. PubMed ID: 3786948 [TBL] [Abstract][Full Text] [Related]
4. Measurement of both protein-bound and total S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood by high-performance liquid chromatography. Bonner HS; Shaw LM J Chromatogr B Biomed Sci Appl; 2000 Mar; 739(2):357-62. PubMed ID: 10755379 [TBL] [Abstract][Full Text] [Related]
5. Determination of WR-1065 and WR-33278 by liquid chromatography with electrochemical detection. Pendergrass JA; Srinivasan V; Kumar KS; Jackson WE; Seed TM J AOAC Int; 2002; 85(3):551-4. PubMed ID: 12083246 [TBL] [Abstract][Full Text] [Related]
6. Measurement of WR-2721, WR-1065, and WR-33278 in plasma. Fahey RC; Newton GL Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1193-7. PubMed ID: 2987166 [TBL] [Abstract][Full Text] [Related]
7. A method for the combined measurement of ethiofos and WR-1065 in plasma: application to pharmacokinetic experiments with ethiofos and its metabolites. Swynnerton NF; Huelle BK; Mangold DJ; Ludden TM Int J Radiat Oncol Biol Phys; 1986 Aug; 12(8):1495-9. PubMed ID: 3019967 [TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic assay using electrochemical detection for the combined measurement of amifostine, WR 1065 and the disulfides in plasma. Korst AE; Vermorken JB; van der Vijgh WJ J Chromatogr B Biomed Sci Appl; 1997 May; 693(1):167-74. PubMed ID: 9200531 [TBL] [Abstract][Full Text] [Related]
9. Determination of the cytoprotective agent WR-2721 (Amifostine, Ethyol) and its metabolites in human blood using monobromobimane fluorescent labeling and high-performance liquid chromatography. Souid AK; Newton GL; Dubowy RL; Fahey RC; Bernstein ML Cancer Chemother Pharmacol; 1998; 42(5):400-6. PubMed ID: 9771955 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of a method for measuring the radioprotective metabolite WR-1065 in plasma using chemical derivatization combined with UHPLC-MS/MS. Simon ES; Reyna D; Lister RJ; Harteg C; Lipka E J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Mar; 1080():82-89. PubMed ID: 29482122 [TBL] [Abstract][Full Text] [Related]
11. Analysis of S-35 labeled WR-2721 and its metabolites in biological fluids. Anderson KW; Krohn KA; Grunbaum Z; Phillips RB; Mahler PA; Menard TW; Spence AM; Rasey JS Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1511-5. PubMed ID: 6090353 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of topoisomerase II alpha activity in CHO K1 cells by 2-[(aminopropyl)amino]ethanethiol (WR-1065). Grdina DJ; Constantinou A; Shigematsu N; Murley JS Radiat Res; 1994 Apr; 138(1):44-52. PubMed ID: 8146299 [TBL] [Abstract][Full Text] [Related]
14. Disposition of the radioprotector ethiofos in the rhesus monkey. Influence of route of administration. Mangold DJ; Miller MA; Huelle BK; Sanchez-Barona DO; Swynnerton NF; Fleckenstein L; Ludden TM Drug Metab Dispos; 1989; 17(3):304-10. PubMed ID: 2568913 [TBL] [Abstract][Full Text] [Related]
15. HPLC and 31P NMR characterization of the reaction between antitumor platinum agents and the phosphorothioate chemoprotective agent S-2-(3-aminopropylamino)ethylphosphorothioic acid (WR-2721). Thompson DC; Wyrick SD; Holbrook DJ; Chaney SG Biochem Pharmacol; 1995 Oct; 50(9):1413-9. PubMed ID: 7503792 [TBL] [Abstract][Full Text] [Related]
16. Equilibrium dialysis studies of the binding of radioprotector compounds to DNA. Smoluk GD; Fahey RC; Ward JF Radiat Res; 1986 Aug; 107(2):194-204. PubMed ID: 3018831 [TBL] [Abstract][Full Text] [Related]
17. Blood thiols following amifostine and mesna infusions, a pediatric oncology group study. Souid AK; Fahey RC; Aktas MK; Sayin OA; Karjoo S; Newton GL; Sadowitz PD; Dubowy RL; Bernstein ML Drug Metab Dispos; 2001 Nov; 29(11):1460-6. PubMed ID: 11602522 [TBL] [Abstract][Full Text] [Related]
18. Determination of WR-1065 in human blood by high-performance liquid chromatography following fluorescent derivatization by a maleimide reagent ThioGlo3. Chen J; Lu Z; Lawrence TS; Smith DE J Chromatogr B Analyt Technol Biomed Life Sci; 2005 May; 819(1):161-7. PubMed ID: 15797534 [TBL] [Abstract][Full Text] [Related]
19. Effect of the radioprotective drugs MEA, DMSO, and WR-2721 on tumor control and skin tolerance in the rat. Moulder JE; Lo PS; Fischer JJ Cancer Treat Rep; 1977 Aug; 61(5):825-33. PubMed ID: 196752 [TBL] [Abstract][Full Text] [Related]
20. Tissue levels of WR-1065, the active metabolite of amifostine (Ethyol), are equivalent following intravenous or subcutaneous administration in cynomolgus monkeys. Bachy CM; Fazenbaker CA; Kifle G; McCarthy MP; Cassatt DR Oncology; 2004; 67(3-4):187-93. PubMed ID: 15557777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]